INPPL1 gene mutations in opsismodysplasia

被引：12

作者：

Fradet, Anais ^{[1
]}

Fitzgerald, Jamie ^{[1
]}

机构：

[1] Henry Ford Hosp Syst, Ctr Bone & Joint, Dept Orthoped Surg, Detroit, MI USA

来源：

JOURNAL OF HUMAN GENETICS | 2017年 / 62卷 / 02期

关键词：

LIPID PHOSPHATASE SHIP2; 2-CONTAINING INOSITOL 5'-PHOSPHATASE-2; AUTOSOMAL RECESSIVE INHERITANCE; SCHNECKENBECKEN DYSPLASIA; CELL POLARITY; SH2; DOMAIN; PROTEIN; POLYMORPHISMS; CANCER; EXPRESSION;

D O I：

10.1038/jhg.2016.119

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

The INPPL1 (inositol polyphosphate phosphatase-like 1) gene encodes the inositol phosphatase, SHIP2 (for src homology 2 domain-containing inositol phosphatase 2). SHIP2 functions to dephosphorylate, and negatively regulate, the lipid second messenger phosphatidylinositol (3,4,5) P3. SHIP2 has been well studied in the area of insulin resistance and obesity but has roles in cancer and other disorders. Recently, it was reported that mutations in INPPL1 cause opsismodysplasia, a rare, autosomal recessive severe skeletal dysplasia. This review focuses on the mutations associated with opsismodysplasia and explores the role of INPPL1/SHIP2 in skeletal development.

引用

页码：135 / 140

页数：6

共 50 条

[1] INPPL1 gene mutations in opsismodysplasia
Anaïs Fradet
Jamie Fitzgerald
Journal of Human Genetics, 2017, 62 : 135 - 140
[2] Opsismodysplasia: implications of mutations in the developmental gene INPPL1
Chai, E. C. C.
Singaraja, R. R.
CLINICAL GENETICS, 2013, 83 (06) : 527 - 529
[3] Exome Sequencing Identifies INPPL1 Mutations as a Cause of Opsismodysplasia
Huber, Celine
Faqeih, Eissa Ali
Bartholdi, Deborah
Bole-Feysot, Christine
Borochowitz, Zvi
Cavalcanti, Denise P.
Frigo, Amandine
Nitschke, Patrick
Roume, Joelle
Santos, Heloisa G.
Shalev, Stavit A.
Superti-Furga, Andrea
Delezoide, Anne-Lise
Le Merrer, Martine
Munnich, Arnold
Cormier-Daire, Valerie
AMERICAN JOURNAL OF HUMAN GENETICS, 2013, 92 (01) : 144 - 149
[4] A Case of Opsismodysplasia with a Novel INPPL1 Variant
Dasar, Tugba
Aypar, Ebru
Utine, Gulen Eda
Simsek-Kiper, Pelin Ozlem
MOLECULAR SYNDROMOLOGY, 2025, 16 (01) : 49 - 54
[5] Exome sequencing identifies a novel INPPL1 mutation in opsismodysplasia
Aritoshi Iida
Nobuhiko Okamoto
Noriko Miyake
Gen Nishimura
Satoshi Minami
Takuya Sugimoto
Mitsuko Nakashima
Yoshinori Tsurusaki
Hirotomo Saitsu
Masaaki Shiina
Kazuhiro Ogata
Shigehiko Watanabe
Hirofumi Ohashi
Naomichi Matsumoto
Shiro Ikegawa
Journal of Human Genetics, 2013, 58 : 391 - 394
[6] Exome sequencing identifies a novel INPPL1 mutation in opsismodysplasia
Iida, Aritoshi
Okamoto, Nobuhiko
Miyake, Noriko
Nishimura, Gen
Minami, Satoshi
Sugimoto, Takuya
Nakashima, Mitsuko
Tsurusaki, Yoshinori
Saitsu, Hirotomo
Shiina, Masaaki
Ogata, Kazuhiro
Watanabe, Shigehiko
Ohashi, Hirofumi
Matsumoto, Naomichi
Ikegawa, Shiro
JOURNAL OF HUMAN GENETICS, 2013, 58 (06) : 391 - 394
[7] Opsismodysplasia Resulting From an Insertion Mutation in the SH2 Domain, Which Destabilizes INPPL1
Li, Bing
Krakow, Deborah
Nickerson, Deborah A.
Bamshad, Michael J.
Chang, Yong
Lachman, Ralph S.
Yilmaz, Alev
Kayserili, Huelya
Cohn, Daniel H.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2014, 164 (09) : 2407 - 2411
[8] INPPL1 gene is associated with the metabolic syndrome but not with diabetic nephropathy in patients with type 1 diabetes
Hyvonen, M. E.
Forsblom, C.
Ihalmo, P.
Soderlund, J.
Sandholm, N.
Parkkonen, M.
Thorn, L.
Lehtonen, S.
Groop, P. -H.
DIABETOLOGIA, 2010, 53 : S136 - S136
[9] Associations of INPPL1 (+1893CC/AA and
Singh, Jaswinder
Kumar, Vikas
Bala, Kiran
Aneja, Ashish
Singh, Jasbir
META GENE, 2021, 29
[10] Underexpression of INPPL1 is associated with aggressive clinicopathologic characteristics in papillary thyroid carcinoma
Zhou, Yi-Li
Zheng, Chen
Chen, Yi-Tong
Chen, Xue-Min
ONCOTARGETS AND THERAPY, 2018, 11 : 7725 - 7731

← 1 2 3 4 5 →